Correlation Between Tigaraksa Satria and Millennium Pharmacon

Can any of the company-specific risk be diversified away by investing in both Tigaraksa Satria and Millennium Pharmacon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tigaraksa Satria and Millennium Pharmacon into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tigaraksa Satria Tbk and Millennium Pharmacon International, you can compare the effects of market volatilities on Tigaraksa Satria and Millennium Pharmacon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tigaraksa Satria with a short position of Millennium Pharmacon. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tigaraksa Satria and Millennium Pharmacon.

Diversification Opportunities for Tigaraksa Satria and Millennium Pharmacon

-0.37

Correlation Coefficient

Tigaraksa Satria  Millennium Pharmacon

Very good diversification

The 3 months correlation between Tigaraksa and Millennium is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Tigaraksa Satria Tbk and Millennium Pharmacon Internati in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Millennium Pharmacon and Tigaraksa Satria is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tigaraksa Satria Tbk are associated (or correlated) with Millennium Pharmacon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Millennium Pharmacon has no effect on the direction of Tigaraksa Satria i.e., Tigaraksa Satria and Millennium Pharmacon go up and down completely randomly.

Pair Corralation between Tigaraksa Satria and Millennium Pharmacon

Assuming the 90 days trading horizon Tigaraksa Satria Tbk is expected to generate 0.38 times more return on investment than Millennium Pharmacon. However, Tigaraksa Satria Tbk is 2.62 times less risky than Millennium Pharmacon. It trades about 0.0 of its potential returns per unit of risk. Millennium Pharmacon International is currently generating about -0.01 per unit of risk. If you would invest  644,961  in Tigaraksa Satria Tbk on September 3, 2024 and sell it today you would lose (29,961) from holding Tigaraksa Satria Tbk or give up 4.65% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Tigaraksa Satria Tbk  vs.  Millennium Pharmacon Internati

Tigaraksa Satria Tbk

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Tigaraksa Satria Tbk has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent forward-looking signals, Tigaraksa Satria is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

Millennium Pharmacon

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Millennium Pharmacon International are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent forward-looking signals, Millennium Pharmacon is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

Pair Trading with Tigaraksa Satria and Millennium Pharmacon

The main advantage of trading using opposite Tigaraksa Satria and Millennium Pharmacon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tigaraksa Satria position performs unexpectedly, Millennium Pharmacon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Millennium Pharmacon will offset losses from the drop in Millennium Pharmacon's long position.

The idea behind Tigaraksa Satria Tbk and Millennium Pharmacon International pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.